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Xylazine (1.1mg/kg), butorphanol (0.02mg/kg), guaifenesin 5%(20mg/kg), andketamine(2.2mg/kg)combinationswere able to
induce short-term surgicalanaesthesia for23.33 ± 2.57min in Spiti ponies with excellent to goodmusclerelaxation and analgesia.
Urinationandneighingwasaconstantfeatureduringrecoveryperiod.BiphasicPwave,biphasicTwave,anddepressedPRsegment
werecommonelectrocardiographic ﬁndings.Biochemicalattributeswerewithinphysiologicallimitsexcept asigniﬁcantincreasein
ALTvaluesduringanaesthesia.Thevaluesreturned tonormalduringrecovery rulingoutanyrenalorhepatictoxicity.Occasionally,
negative T wave, notched P wave, and sinus block were noticed. It is recommended that the anaesthetic combinations xylazine-
butorphanol-guaifenesin-ketamine can be safely used for short-term total intravenous anaesthesia (TIVA) in equines under ﬁeld
conditions.
1.Introduction
Equines are routinely presented to veterinary hospitals for
variety of surgical interventions, and their temperament
often precludes the use of local analgesia without heavy
sedation (Hall and Clarke [1]). The use of total intravenous
anaesthesia (TIVA) helps in reducing a variety of preanaes-
thetic, anaesthetic, and postanaesthetic problems such as
arrhythmias, hypotension, respiratory or ventilatory insuf-
ﬁciency, motor excitement, and anxiety or postanaesthetic
myopathy (Garcia et al. [2]).High-altitudeequinesare hardy
animals which thrive under cold arid conditions, where
extreme cold temperature and low atmospheric oxygen are
considerable factors. Therefore, the aim of the present study
was to evaluate a safe short-term TIVA protocol in Spiti
ponies using xylazine-butorphanol-guaifenesin-ketamine to
manage alargenumber ofsurgical interventionsandmedical
procedures.
2.MaterialandMethods
The present study was carried out in 6 clinically healthy
adult male Spiti ponies, 4.27 ± 1.63 years old and weighing
181.66 ± 32.26kg, presented for castration. Animals were
fasted overnight and water was withheld for 6–8 hours.
Xylazine (Xylazil—100 injection (100mg/mL), ILIUM, Troy
Laboratories, Australia.) (1.1mg/Kg) was administered
intravenously and subsequently at head-down position; the
animals received butorphanol (Butrum (2mg/mL) Aristo
Pharmaceuticals Pvt. Ltd; Mumbai.) at the dose rate of
0.02mg/Kg and 5% guaifenesin (Guaifenesin IP Prudential
Pharmaceuticals Ltd; Andhra Pradesh, India.) (20mg/Kg),
both intravenously. As soon as the signs of ataxia devel-
oped, induction of surgical anaesthesia was achieved by
intravenous administration of ketamine hydrochloride
(Ketamil—100 injection (100mg/mL), ILIUM, Troy Labora-
tories, Australia.) at the rate of 2.2mg/Kg.During induction,
the horses were properly restrained to prevent forward fall.
After induction, the horses were left undisturbed for one
minute, and neck was extended to maintain a patent airway.
The maintenance of anaesthesia, if required (when ﬂinching
of limbs or return of swallowing reﬂex was observed),
was achieved by ketamine hydrochloride 1.0mg/kg, intra-
venously, until movements or swallowing ceased.
The anaesthetic parameters recorded during each clinical
trial were time for sedation/ataxia, time for induction, dura-
tion of surgical anaesthesia, and recovery time. The depth2 Veterinary Medicine International
Table 1: Score card for quality of muscle relaxation.
Quality of muscle relaxation
Score Quality Character
4 Excellent Complete relaxation
3 Good Adequate muscle relaxation for surgical
procedure
2M o d e r a t e Partial relaxation of head, neck, and limb
muscles
1 Poor Rigidity in muscles of neck, head, and limbs
Table 2: Score card for quality of analgesia.
Score Quality Character
0 Excellent No response
1 Good Response to stimuli, nystagmus created
2M o d e r a t e Purposeful movement of limbs, head, or
neck produced
3 Poor Horse moved into sternal position or stood
Table 3: Score card for quality of recovery.
Quality of recovery
Score Quality Character
1 Excellent Horse capable of standing at ﬁrst attempt
2 Very good Horse remained calm and needed two
attempts to stand
3 Good Horse remained calm but needed more than
two attempts to stand
4 Poor
Excitement during recovery with danger of
injury and needed more than one attempt to
stand
5 Very poor Severe excitement during recovery with
injury
of anaesthesia (light or deep) was analyzed by recording
diﬀerent reﬂexes (palpebral, corneal, photopupillary, and
swallowing) and extent of muscle relaxation (relaxation of
neck, jaws, tail, and anal sphincter, Table 1).
Analgesia (using pin prick method to test the response
to noxious stimuli on the coronary band of the front and
hind limbs, the shoulders, and the gaskin) was interpreted as
a response, and score was given ranging from 0 to 3 (Nanda,
[3]) as per Table 2.
A score, ranging from 1 to 5 as per the method of Ringer
et al. [4], was used for the assessment of quality of recovery
from anaesthesia (Table 3).
The clinical parameters like heart rate, respiratory rate,
and rectal temperature were recorded. Respiration rate was
recordedbyobservingcostoabdominalmovementsmanually
and by vital signs monitor (Multi Para Monitor—Execello
BPL, Bangalore, India), heart rate by auscultation and vital
sign monitor, and gingival perfusion time and SpO2 by
tongue transducer attached to vital sign monitor. Electro-
cardiograms (ECGs) were also recorded using bipolar base
apex lead system. The calibrations made were conduction
of 1mV = 1cm and paper speed of 25mm/sec. The
electrocardiograms were analyzed for various conduction
abnormalities if any. All the observations were made before
induction (BI), after induction (AI), during anaesthesia
(DAn-15min after induction), and after recovery (AR).
The venous blood from jugular vein was collected
at diﬀerent time intervals as mentioned above for mon-
itoring of haemoglobin, packed cell volume, and total
leukocyte count using blood cell counter (BC-2800 Vet
Auto Hematology Analyzer—Mindray, China) and various
biochemical parameters, namely, blood glucose, aspartate
aminotransferase, alanine aminotransferase, alkaline phos-
phatase, chloride, total proteins, blood urea nitrogen, and
creatinineusingcommerciallyavailablekitsoncomputerized
semiautomatic blood analyzer (RA-50 Chemistry Analyzer,
Bayer Diagnostics, Baroda, Gujarat, India). Estimation of
sodium and potassium was done by ﬂame photometry. Data
was expressed as Mean ± SEM, and statistical analysis was
carried out by one-way ANOVA with post hoc Dunnett’s test
performed using GraphPad InStat. P value was considered
signiﬁcant when P<. 05and highly signiﬁcant when P<. 01.
3.Resultsand Discussion
The dosages adapted in the present study have been well
documented in the literature (Kerr et al. [5]; Muir et al. [6];
Butera et al. [7]; Kaka et al. [8]). Xylazine and ketamine
combination is commonly used for induction and main-
tenance of anaesthesia in horses [6], whereas the addition
of guaifenesin helps to achieve desirable eﬀects (analgesia,
unconsciousness, and muscle relaxation) associated with
general anaesthesia as menthioned by Muir et al. [9].
Butorphanol, an agonist-antagonist opioid, was used in the
present study for profound sedation and surgical analgesia
because the use of only agonist opioid induces diﬀerent
excitement states during anaesthesia in horses [2].
The onset of sedation (lowering of head) was observed
in 2.5 ± 0.85min, which is because of signiﬁcant muscle
relaxation by xylazine (Hubbell et al. [10]). The sedative
and analgesic property of xylazine is due to CNS depres-
sion mediated by stimulation of alpha 2 receptors (Hsu
[11]). The animals were ataxic at 1.0 ± 0min following
butorphanol and guaifenesin administration. The induction
of surgical anaesthesia was achieved in 2.66 ± 0.66min
following intravenous ketamine. During recovery, limb/head
movement and sternal recumbency was attained in 18.0
± 3.21min and 28.56 ± 2.23min, respectively. Similar
observations have been reported by McCarty et al. [12]a n d
Baetge et al. [13], as they recorded the sternal recumbency
in 30.0min and in 15.0 ± 6.0min, respectively. Standing
ataxia and normal gait were seen at 32.16 ± 3.20min and
48.83 ± 3.99min, respectively, after induction of anaesthesia
with ketamine. Ketamine hydrochloride exerts its eﬀect
on CNS during induction and produces functional and
electrophysiological dissociation of thalamocortical areas
from limbic and other subcortical structures in the brain; as
a result, consciousness is lost (Staﬃeri and Driessen [14]).
Maintenance of anaesthesia was required in two horses by
topping up with ketamine at the dose rate of 1.0mg/kg,Veterinary Medicine International 3
Table 4: Clinical and haematologicaleﬀects following Xylazine-butorphanol-Guaifenesin-Ketamine anaesthesia in Spiti ponies (n = 6).
Parameters (unit) Before induction (BI) After induction (AI) During anaesthesia (DAn) After recovery (AR)
Rectal temp (◦F) 98.65 ± 0.29 98.88 ± 0.41 98.03 ± 0.53 98.13 ± 0.42
Heart rate (per min) 49.50 ± 0.93 43.00 ± 3.44 40.66 ± 4.03 42.00 ± 2.63
Respiratory rate (per min) 28.00 ± 4.93 16.33 ± 1.48 19.33 ± 3.30 26.17 ± 3.06
Hb (g/dL) 10.03 ± 0.43 9.92 ± 0.71 9.60 ± 0.36 10.93 ± 1.22
PCV (%) 26.43 ± 1.17 27.52 ± 1.57 25.45 ± 1.04 26.60 ± 0.96
TLC (thous./mm3)8 . 8 7 ± 2.16 8.17 ± 1.87 8.75 ± 0.70 8.29 ± 0.75
IV (total dose approximating to 140mg). In the present
study, 5 of the Spiti ponies had excellent recoveries with
only one pony taking two attempts to stand with moderate
ataxia. In general, horses induced anaesthesia with xylazine
and ketamine experience smooth recoveries characterized
by a roll to sternal recumbency and a single attempt to
stand (Aubin and Mama [15]). Urination and neighing
was a constant feature during recovery period except in
one horse. The lacrimation was observed in three horses
probably indicating light plane of anaesthesia. The palpebral
and corneal reﬂexes were suppressed after induction and
during anaesthesia. Eye evaluation, which is usually used to
judge the depth of anaesthesia, is of limited value following
administration of ketamine because of the responses like
voluntary blinking, nystagmus(Bertone and Horspool [16]),
and lacrimation. This eﬀect may be attributed to ketamine
which is often referred to as cateleptoid anaesthesia, which
diﬀers markedly from the classical signs of anaesthesia.
Ketamineappears toalterthereactivity oftheCNStovarious
sensory impulses without blocking the sensory inputs at
spinal or brain stem levels. The input may reach the cortical
receiving areas but fails to be perceived because of the
depression or disorganization of the associated areas during
theperiod ofanaesthesia (Sparketal.[17];Wright[18]).The
swallowing reﬂex was depressed in all the operated horses.
The TIVA combination used in the present study pro-
ducedexcellenttogoodmusclerelaxation duringanaesthesia
in all the animals as evidenced by relaxation of jaw, neck,
tail, and anal sphincter. The muscle relaxation is largely
attributed to guaifenesin which acts centrally by depressing
or blocking nerve impulse transmission at subcortical areas
of brain, brainstem, and spinal cord (Cullen [19]). The
loss of anal tone was noticed initially after induction and
was last to return to normal during recovery. There was
complete to moderate analgesia during anaesthesia in all the
animals which remained for 23.33 ± 2.57min following the
induction of anaesthesia as has also been demonstrated by
Geiser and Henton [20], where analgesia in horses remained
for 30–35min which is due to reduced electrical activity of
brain produced by a combination of xylazine and ketamine
(Purohit et al. [21]).
The rectal temperature remained unaﬀected during the
period of study, whereas nonsigniﬁcant decreases in heart
rate and respiration rate were observed after induction and
during anaesthesia (Table 4). However, the changes recorded
were within normal range. A similar trend was observed
following continuous intravenous triple drip of xylazine-
ketamine-guaifenesin [3]. The decrease in respiration rate
can be related to direct depression of respiratory centres
by xylazine (Rings and Muir [22]). Butorphanol is also a
potential respiratory depressant drug although no serious
eﬀect was observed by Robertson et al. [23]w h e ni tw a s
injected in healthy horses. The decrease in the heart rate
is attributed to xylazine-induced vagal stimulation. All the
hematological parameters, namely, hemoglobin, PCV, and
TLC remained within the normal range in the present study
(Table 4). A signiﬁcant decrease in PCV and TLC and a
nonsigniﬁcant decrease in Hb have been reported following
continuous intravenous triple drip of xylazine-ketamine-
guaifenesin in spiti ponies [3]. The mean SpO2 value in
equines remained within 82.18 ± 5.33 and 87 ± 2.94%
during surgical plan of anaesthesia. If at all we consider
it as hypoxemia (as the base values of SpO2 could not be
obtained in the present study), it could be due to some drop
in oxygenation probably happened as is commonly seen in
horses under general anaesthesia because the assumption of
lateral recumbency is associated with the development of
ventilation-perfusion mismatches and the shunting of blood
through the lungs resulting in less than optimal oxygenation
(Hubbel [24]). Also it could be due to the low atmospheric
oxygen since the anaesthetic trials were conducted at high
altitude (1500msl).
Biphasic T wave was a constant observation in all the
horses before administration of any drug (Figure 1). In
one horse, PR segment was depressed, whereas ST segment
elevation was noticed in another two horses at base. After
induction of anaesthesia, biphasic P wave, biphasic T wave,
shortening of QRS segment, and slight elevation of ST
segment were recorded in all the animals. All the ECG
changes recorded in this study represent normal impulse
conductionandhenceareofnoclinicalrelevance.Occasional
conduction abnormalities seen during anaesthesia in diﬀer-
ent Spiti ponies are likely a consequence of xylazine used in
the present study.
All the preinduction plasma samples of Spiti ponies
evaluated for various biochemical parameters were within
normal range (Table 5). There was a highly signiﬁcant (P<
.01) increase in the plasma ALT values during anaesthesia.
The increase in ALT values could probably be due to
alteration in cell membrane permeability which may permit
these enzymes to leak from cells with intact membrane
(Tiwari et al. [25]). Also a signiﬁcant (P<. 05) increase4 Veterinary Medicine International
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Biphasic P wave
ST segment elevation
Figure 1: Electrocardiogram of a Spiti pony following xylazine-butorphanol-guaifenesin-ketamine anesthesia showing diﬀerent wave
changes.
Table 5: Biochemical eﬀects followingXylazine-butorphanol-Guaifenesin-Ketamine anaesthesia in Spiti ponies (n = 6).
Parameters (unit) Before induction (BI) After induction (AI) During anaesthesia (DAn) After recovery (AR)
Sodium (mEq/L) 128.05 ± 11.70 122.80 ± 11.16 113.93 ± 5.32 109.80 ± 5.72
Potassium (mEq/L) 4.17 ± 0.39 3.93 ± 0.29 4.12 ± 0.69 3.29 ± 0.31
Chloride (mEq/L) 79.15 ± 12.44 81.30 ± 7.50 84.39 ± 9.47 77.41 ± 5.43
Glucose (mg/dL) 75.50 ± 11.03 119.17 ± 14.77 125.66 ± 13.66 120.83 ± 13.42
Total proteins (g/dL) 8.60 ± 0.49 10.60 ± 0.49 10.83 ± 0.61 10.36 ± 1.06
AST (U/L) 241.00 ± 29.24 200.33 ± 25.39 176.83 ± 29.37 169.16 ± 29.78
ALT (U/L) 13.60 ± 0.63 18.92∗∗± 0.60 18.44∗∗± 0.62 13.18 ± 0.71
ALKP(U/L) 123.00 ± 4.12 138.00∗± 3.54 111.17 ± 2.48 118.50 ± 3.56
BUN (mg/dL) 25.70 ± 2.97 24.33 ± 2.18 23.28 ± 1.66 22.05 ± 1.98
Creatinine (mg/dL) 0.81 ± 0.05 0.74 ± 0.05 0.78 ± 0.06 0.84 ± 0.14
∗P <. 05; ∗∗P <. 01.
in plasma ALKP values was noticed immediately after the
induction of anaesthesia. Since the range of ALKP values
in horses is wide that a change in its value is of no clinical
relevance. Although there was evidence of nonsigniﬁcant
(P>. 05) hyperglycemia throughout the period of study
following the induction of anaesthesia, the clinical relevance
of such an increase in the glucose levels cannot be ruled
out. The increase in plasma glucose level was probably
due to an alpha2 adrenergic inhibition of insulin release
by stimulation of alpha2 receptors in the pancreatic β-cells
(Angel and Langer [26]). Ketamine hydrochloride generally
increases norepinephrine blood levels and turnover. Since
norepinephrine aﬀects gluconeogenesis and glycogenolysis
and also decreases insulin production, enhanced hyper-
glycemic eﬀects after ketamine administration are obvious.
A signiﬁcant hyperglycemia following general anesthesiaVeterinary Medicine International 5
has been reported in horses (Young et al. [27]; Singh
et al. [28]). However, since these changes were statistically
nonsigniﬁcant; therefore, they reﬂect no eﬀect on renal
blood ﬂow in the present study. The remaining biochemical
parameters remained within normal range throughout the
period of study reﬂecting no alterations in body electrolyte
balance as well as absence of any hepatic or renal toxicity in
the present study.
4.Conclusion
It was concluded that xylazine (1.1mg/kg), butorphanol
(0.02mg/kg), guaifenesin 5% (20mg/kg), and ketamine
(2.2mg/kg) combination can safely be used for total intra-
venous anaesthesia for short-term procedures in equines
under ﬁeld conditions where the monitoring facilities are
meager. The combination produces minimal side eﬀects
without any hepatic or renal toxicity.
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